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Abstract
Background: Prevention of mother to child transmission (PMTCT) is an important part of the effort to
control HIV. PMTCT services are mostly provided at public sector government hospitals in India.
Systematic data on the cost and efficiency of providing PMTCT services in India are not available readily
for further planning.
Methods: Cost and output data were collected at 16 sampled PMTCT centres in the south Indian state
of Andhra Pradesh using standardized methods. The services provided were analysed, and the relation of
unit cost of services with scale was assessed.
Results: In the 2005–2006 fiscal year, 125,073 pregnant women received PMTCT services at the 16
centres (range 2,939 to 20,896, median 5,679). The overall HIV positive rate among those tested was
1.67%. Of the total economic cost, the major components were personnel (47.3%) and recurrent goods
(31.7%). For the 16 PMTCT centres, the average economic cost per post-HIV-test counselled pregnant
woman was Indian Rupees (INR) 98.9 (US$ 2.23), ranging 2.7-fold from INR 71.4 (US$ 1.61) to INR 189.9
(US$ 4.29). The economic cost per mother-neonate pair who received nevirapine had a higher variation,
ranging 41-fold for the 16 centres from INR 4,354 (US$ 98) to INR 179,175 (US$ 4,047), average INR
10,210 (US$ 231), with very high unit cost at some centres where HIV prevalence among pregnant women
and the total volume of services were both low. Scale had a significant inverse relation with both of the
unit costs, per post-HIV-test counselled pregnant woman and per mother-neonate pair who received
nevirapine. In addition, HIV prevalence among pregnant women had a significant inverse relation with unit
cost per mother-neonate pair who received nevirapine.
Conclusion: Although the variation between PMTCT centres for unit cost per post-HIV-test counselled
pregnant woman was modest that per mother-neonate pair receiving nevirapine was over 40-fold. The
extremely high unit cost for each mother-neonate pair receiving nevirapine at some centres suggests that
the new approach of combining PMTCT services with voluntary counselling and testing services that has
recently been started in India could potentially offer better efficiency.
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Background
Although the estimate of the number of people living with
HIV in India has been reduced to less than half recently
based on new population-based data, this is still one of
the highest numbers for a country in the world [1-4]. The
south Indian state of Andhra Pradesh is estimated to have
the highest number of HIV infected persons in India, and
had the highest HIV positive rate (1.26%) among preg-
nant women tested at public sector sentinel centres in the
sentinel surveillance of 2006 [4]. Prevention of Mother to
Child Transmission (PMTCT) of HIV is an important
component of the HIV prevention services in this state.
The Reproductive and Child Health survey of 2002–2004
estimated that in Andhra Pradesh 60.9% of the deliveries
were institutional, with 22.1% in public sector health
facilities and 38.8% in the private sector [5]. PMTCT serv-
ices are available only at some public sector facilities and
therefore the majority of pregnant women are not receiv-
ing these services. The PMTCT services were started in
Andhra Pradesh at one centre situated in a tertiary hospi-
tal attached to a medical college in the year 2000. Subse-
quently 13 PMTCT centres were started in hospitals
attached to a medical college in the year 2002, and 23
PMTCT centres were started in hospitals not attached to a
medical college in the year 2003. During the 2005–2006
fiscal year 64 more PMTCT centres were started, mostly at
smaller area hospitals and community health centres
which are not attached to a medical college. We assessed
the cost and efficiency of the PMTCT centres in Andhra
Pradesh to inform further planning of HIV prevention
services.
Methods
The methods used in this study were adapted from the
multi-country Prevent AIDS Network for Cost Effective-
ness Analysis (PANCEA) study [6-9]. Description of the
methods relevant for this paper follows.
Selection of PMTCT centres
At the time of data collection in mid-2006, there were 37
public sector PMTCT centres that had functioned through-
out the 2005–2006 fiscal year in Andhra Pradesh. Another
64 PMTCT centres were started towards the end of 2005
but because they had not functioned for the full
2005–2006 fiscal year they were not considered for our
sample. Andhra Pradesh has three geographic regions: the
northern Telangana region has the state capital and nine
other districts, the eastern Coastal region has nine dis-
tricts, and the southern Rayalseema region has four dis-
tricts with a population nearly half that in either of the
other two regions. We used the three geographic regions
of Andhra Pradesh as the strata for sampling. Within each
geographic region we selected about 50% of the centres
situated in hospitals attached to a medical college and
about 50% situated in hospitals not attached to a medical
college, so that we could assess the efficiency of different
sizes of hospitals – the former are much larger than the
latter. Within these two strata, 16 PMTCT centres were
randomly sampled to obtain six centres each in the Telan-
gana and Coastal regions and four centres in the Ray-
alseema region.
Data collection procedures
Data were collected for the April 2005 – March 2006 fiscal
year at the 16 sampled PMTCT centres during June – July
2006. Data collection included a history of the PMTCT
centre and detailed cost and output data by month. For-
mal consent to collect data was obtained from the Andhra
Pradesh State AIDS Control Society (APSACS) and the
superintendents of the hospitals where the PMTCT centres
were located. Data collection at each centre was started
with an interview with the PMTCT medical officer/s (a
microbiologist and/or a gynaecologist and/or a paediatri-
cian), counsellor(s), and laboratory technician. The inter-
view contained structured open-ended questions
regarding the history of the PMTCT centre and operational
and community factors that affect the demand and supply
of services. After this, cost and output data was collected.
Data collection at a PMTCT centre was done by two inves-
tigators and lasted for one week. Data were recorded in the
field on laptop computers in MS Excel and MS Word files.
Cost data
Data on both financial and economic cost were collected,
the latter being the true resource cost incurred. The cost
data were collected under five heads: rentals, personnel,
capital goods, recurrent goods and recurrent services. Sim-
ilar costing methods were used for all the PMTCT centres.
To convert Indian Rupees (INR) into United States Dol-
lars (US$) the average exchange rate of INR 44.27 = US$1
was used for the April 2005 – March 2006 fiscal year [10].
All PMTCT centres were located in a parent public sector
hospital, and as such no rent was paid. In order to calcu-
late economic cost of the rental equivalent, the floor area
occupied by each PMTCT centre was determined, rent
rates obtained from three sources in that area for health
facilities for the 2005–2006 fiscal year, and the average of
these rates applied to the PMTCT area.
Salary cost was computed for all personnel contributing to
the work of the PMTCT centre, which included the medi-
cal officers, counsellor(s) and laboratory technician. For
personnel contributing part time to the PMTCT work,
only that proportion of salary was included in the PMTCT
salary cost. For example, if the medical officers were con-
tributing only one-third of their time for PMTCT and the
rest of the time to teaching and/or providing other clinical
services, then only one-third of their salary was includedBMC Health Services Research 2008, 8:26 http://www.biomedcentral.com/1472-6963/8/26
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in the personnel cost. Information about the salaries of
the personnel was collected from the official records of
the accounts section of the hospital of which the PMTCT
centre was a part. In addition to the regular salary, if some
personnel were paid fringe benefits, these were included
in the cost.
Capital goods included furniture, electrical fixtures, air
conditioner, air cooler, refrigerator, centrifuge, computer,
needle and syringe destroyer, hot air oven, micropipette,
weighing machine, infantometer and public address sys-
tem. If information about the cost of the capital goods was
not available from the PMTCT centre or its parent public
sector hospital, the market price was determined from
retail sellers of these goods. The life of capital goods was
assumed to be five years, and therefore, one-fifth of the
cost was allocated to the 2005–2006 fiscal year if the good
was used for the full year. If a capital good was purchased
in the middle of this fiscal year and used only for half the
year, the cost allocated for this item was half of the yearly
cost. If a capital good, for example refrigerator or centri-
fuge was also being used for work other than that of the
PMTCT centre, a determination was made from the
PMTCT centre staff about the proportion of use for
PMTCT centre work and that proportional cost was allo-
cated to the PMTCT centre.
Recurrent goods utilised at the PMTCT centres included
HIV test kits, nevirapine tablets and syrup, disposable sur-
gical kits, disposable delivery kits, needles and syringes,
gloves, sterillium, spirit, sodium hypochlorite solution,
distilled water, test tubes, serum containers, droppers,
micro-tips, cotton, filter paper, soap, stationery and some
miscellaneous items. Several recurrent goods were not
directly purchased by the PMTCT centres, for example, the
HIV test kits, nevirapine tablets and nevirapine syrup were
supplied to the PMTCT centres by APSACS. These goods
are purchased in bulk from commercial manufacturers.
Information was obtained from the manufacturers about
the prices for such bulk purchases during the 2005–2006
fiscal year and these were used as the cost. Attempts were
made to get the cost of the other goods from the records
of the PMTCT centres, which if available were used for
analysis. If not available, three quotations for these goods
were obtained from the market for the 2005–2006 fiscal
year and the average of these taken as the cost.
Recurrent services included training of staff, cleaning and
building maintenance, electricity, water, telephone, waste
disposal, photocopying, postage and courier, and some
miscellaneous items. The cost for staff training was calcu-
lated by including travel fare, per diem, trainer fees, train-
ing materials, and training facility cost, information about
which was obtained not only from the PMTCT centres,
which incurred some of these costs, but also from the
APSACS, which incurred many of these costs. The cost of
building maintenance was calculated based on the space
occupied by the PMTCT centre. Electricity and water costs
were based on applying the market rates to the estimated
usage. Telephone and other recurrent services costs were
calculated based on actual usage.
For financial cost calculations the rentals were excluded
because the infrastructure was already in place when the
government decided to provide PMTCT services. The sal-
ary of the medical officer was excluded because the medi-
cal officer is not paid anything extra for providing the
PMTCT services. The annualised cost of capital goods pro-
vided by the hospital was also excluded because these cap-
ital goods were already in place before the PMTCT centres
started. However the cost of the recurrent goods and serv-
ices provided by the hospital were included because that
is an additional cost for providing PMTCT services.
Output data
Detailed data were obtained from the written records of
the PMTCT centres regarding the services provided by
month for the 2005–2006 fiscal year. These included the
number, format and duration of pre- and post-HIV-test
counselling sessions; number of HIV tests conducted and
results; number of mother-neonate pairs who received
nevirapine; number of medical terminations of pregnancy
in HIV positive women; number of deliveries conducted
in HIV negative and positive women; and number of
spouse/partners tested and post-HIV-test counselled.
Characteristics of programme operation were ascertained,
including client characteristics and types of HIV tests
administered.
Quality control
Quality control measures included comprehensive train-
ing of the data collection team in standardised methods
including their understanding of all data issues, full back-
up and justification for any data recorded, supervision of
data collection at each PMTCT centre, thorough review by
the study team of the data obtained at each PMTCT centre,
and contacting the PMTCT centres again to obtain infor-
mation about data issues that needed clarification after
the review.
Data analysis
After review of data and clarifications, analysis of the out-
puts and cost data was done using SPSS and Microsoft
Excel softwares. Efficiency of PMTCT centres was assessed
for two outputs, economic cost per post-HIV-test coun-
selled pregnant women (which includes information that
they and their neonates could get anti-retroviral treatment
at the time of delivery if they were HIV positive) and eco-
nomic cost per mother-neonate pair receiving nevirapine
if the mother were HIV positive. The relation betweenBMC Health Services Research 2008, 8:26 http://www.biomedcentral.com/1472-6963/8/26
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scale and unit costs was analysed using regression fits, sep-
arately for the larger PMTCT centres situated in tertiary
hospitals attached to a medical college and those situated
in hospitals not attached to a medical college, and also
combined for these two types of PMTCT centres. The rela-
tion between HIV prevalence among pregnant women at
the PMTCT centres and the unit cost per mother-neonate
pair receiving nevirapine was also assessed using regres-
sion analysis. Bivariate regression types available in
Microsoft Excel (exponential, linear, logarithmic, polyno-
mial and power) were used, and the relations with the
best fit are presented.
Results
A total of 125,073 pregnant women received post-HIV-
test counselling at the 16 PMTCT centres in the fiscal year
2005–2006, ranging from 2,939 to 20,896 in a centre,
with a median of 5,679 and a mean of 7,817 (Table 1).
The average number of post-HIV-test counselled at the 8
PMTCT centres situated in hospitals attached to a medical
college was 11,368 versus 4,266 at the 8 PMTCT centres
situated in hospitals not attached to a medical college.
Of all pregnant women tested for HIV, 1.67% were found
positive. The HIV positive rate was highest in the coastal
Andhra region at 2.65% versus 1.17% in the other two
regions of the state. The overall drop-out rate between
tests done and post-HIV-test counselled was 5.3%, and
that for HIV positive women was somewhat higher at
6.4% (Table 1). The latter was highest in Coastal Andhra
(9.4%). The HIV positive rate was similar in PMTCT cen-
tres situated in hospitals attached to a medical college and
those not attached to a medical college, but the drop-out
rates were lower in the latter (Table 1).
The total number of deliveries at the 16 PMTCT centres in
the 2005–2006 fiscal year was 91,312, of which 1,322
(1.45%) were in HIV positive women (Table 2). The
PMTCT centres provide nevirapine to the HIV positive
mothers and neonates to prevent vertical transmission of
HIV. The mother was given one tablet of 200 mg at the
onset of labour and the neonate was given 2 mg/kg body
weight within 72 hours of birth. Of the 1,322 HIV positive
deliveries, 1,212 (91.7%) mother-neonate pairs received
nevirapine, varying from 2 to 224 at the 16 PMTCT cen-
tres, representing 80.9% to 100% of the HIV positive
deliveries. Nevirapine was not administered in 110
Table 1: HIV testing at PMTCT centres in the 2005–2006 fiscal year.
PMTCT centre
serial number
Number of HIV
tests done in
pregnant women
Number (%)
HIV positive
Number of post-
HIV-test counselled
pregnant women
Number (%)
tested but did not
collect results
Number of HIV
positive post-test
counselled
Number (%) of
HIV positive who
did not collect test
results
At hospitals attached to medical college
2 10605 81 (0.76) 10331 274 (2.58) 77 4 (4.94)
5 11989 372 (3.10) 10039 1950 (16.26) 321 51 (13.71)
7 5615 118 (2.10) 4659 956 (17.03) 100 18 (15.25)
8 9185 125 (1.36) 8726 459 (5.00) 124 1 (0.80)
9 11895 364 (3.06) 11496 399 (3.35) 341 23 (6.32)
12 12842 147 (1.14) 12263 579 (4.51) 136 11 (7.48)
13 21363 253 (1.18) 20896 467 (2.19) 253 0 (0.00)
15 13556 117 (0.86) 12537 1019 (7.52) 108 9 (7.69)
Sub-total 97050 1577 (1.62) 90947 6103 (6.29) 1460 117 (7.42)
At hospitals not attached to medical college
1 5078 80 (1.58) 5078 0 (0.00) 80 0 (0.00)
3 3019 17 (0.56) 2963 56 (1.85) 17 0 (0.00)
4 5057 138 (2.73) 4831 226 (4.47) 136 2 (1.45)
6 3011 79 (2.62) 2939 72 (2.39) 77 2 (2.53)
10 3688 36 (0.98) 3631 57 (1.55) 36 0 (0.00)
11 5989 130 (2.17) 5777 212 (3.54) 116 14 (10.77)
14 5843 112 (1.92) 5580 263 (4.50) 109 3 (2.68)
16 3372 31 (0.92) 3327 45 (1.33) 29 2 (6.45)
Sub-total 35057 623 (1.78) 34126 931 (2.66) 600 23 (3.69)
Total 132107 2200 (1.67) 125073 7034 (5.32) 2060 140 (6.36)BMC Health Services Research 2008, 8:26 http://www.biomedcentral.com/1472-6963/8/26
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(8.3%) deliveries because either the mother arrived after
onset of labour, or the neonate was assessed not fit to be
administered nevirapine, or it was a still birth, or the
mother was infected with HIV-2.
The PMTCT centres also provide the option of medical ter-
mination of pregnancy (MTP) to HIV positive women
during the first trimester of pregnancy. In the 2005–2006
fiscal year, the number of women opting for MTP was 200
at the 16 PMTCT centres (Table 2). The average ratio of the
number of MTPs to the number of HIV positive deliveries
was 0.15, varying from 0 to 0.52. The proportion of HIV
positive mother-neonate pairs who received nevirapine
and the ratio of MTPs to HIV positive deliveries were sim-
ilar in PMTCT centres situated in hospitals attached to a
medical college and those not attached to a medical col-
lege (Table 2).
The PMTCT centres also provide counselling and testing
services to the spouse or partner of HIV positive pregnant
women. Out of 2,060 HIV positive pregnant women who
received post-HIV-test counselling, 1,075 (52.2%) got
their spouse/partner tested of which 785 (73%) were HIV
positive (Table 3). These proportions were similar in
PMTCT centres situated in hospitals attached to a medical
college and those not attached to a medical college.
The total economic cost of the 16 PMTCT centres in the
2005–2006 fiscal year ranged from INR 358,349 (US$
8,095) to INR 2,263,496 (US$ 51,129) with a mean of
INR 773,385 (US$ 17,470) and a median of INR 642,471
(US$ 14,513) (Table 4). Personnel costs accounted for
47.3% of the total economic cost (range 41.2–62.1%),
recurrent goods 31.7% (range 19.3–42.4%), rentals
13.2% (range 8.7–20.3%), recurrent services 6.3% (range
2.4–12.9%) and capital goods 1.5% (range 0.8–2.4%).
The total economic cost of the 8 PMTCT centres situated
in hospitals attached to a medical college averaged INR
1,082,390 (US$ 24,450) whereas that of the 8 PMTCT
centres situated in hospitals not attached to a medical col-
lege averaged INR 464,379 (US$ 10,490). The financial
cost of all 16 PMTCT centres combined was 70.3% of the
economic cost; this was slightly higher for PMTCT centres
situated in hospitals attached to a medical college
(72.4%) versus those not attached to a medical college
(65.3%).
Table 2: Hospital deliveries, medical termination of pregnancy (MTP) and nevirapine (NVP) administered in PMTCT centres in the 
2005–2006 fiscal year.
PMTCT centre 
serial number
Total number
of deliveries
Number (%) of
HIV positive
deliveries
Number of HIV
positive MTPs
Ratio of MTPs to
HIV positive
deliveries
Number of
mother-neonate
pairs given NVP
% mother-neonate
pairs given NVP of
HIV positive deliveries
At hospitals attached to medical college
2 6235 40 (0.64) 13 0.33 38 95.0
5 6052 242 (4.00) 48 0.20 224 92.6
7 4007 134 (3.34) 24 0.18 121 90.3
8 6884 70 (1.02) 8 0.11 64 91.4
9 9258 215 (2.32) 10 0.05 203 94.4
12 8696 76 (0.87) 6 0.08 66 86.8
13 18336 157 (0.86) 34 0.22 127 80.9
15 8823 69 (0.78) 14 0.20 67 97.1
Sub-total 68291 1003 (1.47) 157 0.16 910 90.7
At hospitals not attached to medical college
1 3239 44 (1.36) 2 0.05 42 95.5
3 3177 2 (0.06) 0 0.00 2 100
4 2458 54 (2.20) 28 0.52 52 96.3
6 1229 36 (2.93) 2 0.06 36 100
10 2449 13 (0.53) 0 0.00 13 100
11 4188 103 (2.46) 6 0.06 98 95.1
14 3432 62 (1.81) 5 0.08 54 87.1
16 2849 5 (0.18) 0 0.00 5 100
Sub-total 23021 319 (1.39) 43 0.13 302 94.7
Total 91312 1322 (1.45) 200 0.15 1212 91.7BMC Health Services Research 2008, 8:26 http://www.biomedcentral.com/1472-6963/8/26
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The average economic cost per post-HIV-test counselled
pregnant woman for the 16 PMTCT centres was INR 98.9
(US$ 2.23), ranging from INR 71.4 (US$ 1.61) to INR
189.9 (US$ 4.29). This average economic cost was 14.4%
higher at PMTCT centres situated in hospitals not attached
to a medical college (INR 108.9, US$ 2.46) as compared
with those attached to a medical college (INR 95.2, US$
2.15). The relation between scale and unit economic cost
was mostly inverse with a suggestion of an upward inflec-
tion at the highest end of the scale for PMTCT centres sit-
uated in hospitals attached to a medical college, with the
best fit obtained using a quadratic function (Figure 1).
This relation was inverse without an upward inflection for
PMTCT centres not attached to a medical college, with the
best fit obtained using a power function (Figure 1). If all
16 PMTCT centres were consider together, the best fit for
this relation was obtained using a quadratic function (R2
= 0.42, p = 0.03).
The average economic cost per mother-neonate pair who
received nevirapine for the 16 PMTCT centres was INR
10,210 (US$ 231), ranging 41-fold from INR 4,354 (US$
98) to INR 179,175 (US$ 4,047). This average economic
cost was 29.3% higher for the relatively smaller PMTCT
centres situated in hospitals not attached to a medical col-
lege (INR 12,301, US$ 278) as compared with the larger
PMTCT centres situated in hospitals attached to a medical
college (INR 9,516, US$ 215). There was a significant
inverse relation between scale and unit economic cost,
with the best fit obtained using a power function for
PMTCT centres situated in hospitals attached to a medical
college as well as those not attached to a medical college
(Figure 2). If all 16 PMTCT centres were consider together,
the best fit for this relation was also obtained using a
power function (R2 = 0.87, p < 0.001). There was also a
significant inverse relation between HIV prevalence
among pregnant women and economic cost per mother-
neonate pair who received nevirapine, with the best fit
obtained using a power function for both the PMTCT cen-
tres situated in hospitals attached to a medical college and
those not attached to a medical college (Figure 3). The two
PMTCT centres that had extremely high unit cost per
mother-neonate pair who received nevirapine (INR
179,175 [US$4,047] and INR 77,622 [US$ 1,753]) had
HIV prevalence among pregnant women less than 1% and
a relatively low total number of pregnant women who
received PMTCT services, resulting in only 2 and 5
mother-neonate pairs receiving nevirapine in a fiscal year
Table 3: Services provided by PMTCT centres to spouse/partners of HIV positive women in the 2005–2006 fiscal year.
PMTCT centre 
serial number
Number of HIV positive post-test
counselled pregnant women
Number (%) of spouse/partners
tested for HIV and counselled
Number (%) of spouse/
partners HIV positive
At hospitals attached to medical college
2 77 61 (79.2) 53 (86.9)
5 321 161 (50.2) 125 (77.6)
7 100 62 (62.0 49 (79.0)
8 124 57 (46.0) 46 (80.7)
9 341 99 (29.0) 74 (74.7)
12 136 77 (56.6) 46 (59.7)
13 253 146 (57.7) 96 (65.8)
15 108 70 (64.8) 51 (72.9)
Sub-total 1460 733 (50.2) 540 (73.7)
At hospitals not attached to medical college
1 80 44 (55.0) 23 (52.3)
3 17 10 (58.8) 7 (70.0)
4 136 93 (68.4) 74 (79.6)
6 77 37 (48.1) 24 (64.9)
10 36 14 (38.9) 14 (100)
11 116 72 (62.1) 52 (72.2)
14 109 62 (56.9) 41 (66.1)
16 29 10 (34.5) 10 (100)
Sub-total 600 342 (57.0) 245 (71.6)
Total 2060 1075 (52.2) 785 (73.0)BMC Health Services Research 2008, 8:26 http://www.biomedcentral.com/1472-6963/8/26
Page 7 of 11
(page number not for citation purposes)
(centres 3 and 16 in Tables 1 and 5). Both these centres
were situated in hospitals not attached to a medical col-
lege.
Discussion
This study of public sector PMTCT centres in the Indian
state of Andhra Pradesh reveals that these centres provide
counselling and testing services to pregnant women,
administer nevirapine to HIV positive mothers and
neonates, provide HIV positive pregnant women with the
option of medical termination of pregnancy if they are
still in the first trimester of pregnancy, and provide coun-
selling and testing to the spouse or partner of HIV positive
women.
The relatively modest 5–7% pregnant women not receiv-
ing post-HIV-test counselling is related to the practice of
using rapid tests and handing over results on the same
day. During post-HIV-test counselling, the HIV positive
pregnant women are advised to bring their spouse/part-
ners for counselling. About half of the HIV positive preg-
nant women brought their spouse/partners for testing. Of
the spouses/partners tested, 73% were found positive.
Further efforts to increase the proportion of spouses/part-
ners counselled and tested would be useful.
The relation between unit economic cost and scale was
mostly inverse. An upward inflection was observed at the
highest end of the scale for post-test-counselled pregnant
women at large PMTCT centres situated in hospitals
attached to a medical college, which suggested that the
unit cost may start increasing beyond about 14,000 post-
test-counselled pregnant women in a year. This however
should be interpreted with caution as the upward inflec-
tion was only due to one data point. Such an upward
inflection at the higher end of the scale has also been sug-
gested in data from voluntary counselling and testing
(VCT) centres and sex worker programmes for HIV pre-
vention in this Indian state [11,12]. We have recently
reported a predominantly inverse relation between unit
Table 4: Economic cost of PMTCT centres in the 2005–2006 fiscal year.
PMTCT centre 
serial number
Total economic 
cost (INR)
Total economic 
cost (USD)
Economic cost (%)
Personnel Recurrent 
goods
Recurrent 
services
Capital goods Rentals
At hospitals attached to medical college
2 902383 20384 42.8 33.5 10.1 1.5 12.1
5 1162988 26270 41.2 39.0 8.5 1.7 9.6
7 828229 18709 45.5 27.8 12.8 1.8 12.2
8 679994 15360 46.1 39.6 3.4 1.9 9.0
9 998853 22563 43.0 42.4 3.6 0.9 10.2
12 875222 19770 49.7 38.3 2.4 1.0 8.7
13 2263496 51129 47.4 25.6 5.7 1.8 19.5
15 947957 21413 42.4 32.2 8.9 1.2 15.4
Sub-total 8659122 195598 45.0 33.5 6.8 1.5 13.3
At hospitals not attached to medical college
1 455197 10282 54.3 28.6 4.6 1.4 11.1
3 358349 8095 62.1 23.3 4.6 1.4 8.7
4 501213 11322 54.4 29.4 3.1 1.4 11.8
6 558155 12608 56.4 19.3 2.7 1.3 20.3
10 422372 9541 56.6 22.8 3.2 2.4 15.0
11 426687 9638 43.1 40.6 4.4 2.4 9.5
14 604947 13665 41.3 30.5 12.9 0.8 14.6
16 388110 8767 59.1 26.2 3.5 1.8 9.4
Sub-total 3715030 83918 52.7 27.6 5.2 1.6 13.0
Total 12374152 279516 47.3 31.7 6.3 1.5 13.2
INR is Indian Rupee.
US$ 1 = INR 44.27 (average exchange rate for fiscal year April 2005 – March 2006) [10]BMC Health Services Research 2008, 8:26 http://www.biomedcentral.com/1472-6963/8/26
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economic cost and scale for over 200 HIV prevention pro-
grams of various types studied as part of the PANCEA
study in five low- and middle-income countries [13].
The unit cost for mother-neonates who received nevirap-
ine varied very widely between PMTCT centres, over 40-
fold. The extremely high unit costs were found in two
PMTCT centres situated in relatively small hospitals not
attached to a medical college that provided nevirapine to
only 2 and 5 mother-neonate pairs in a fiscal year because
of relatively low HIV prevalence and total number of preg-
nant women served. This has particular significance for
further planning of PMTCT services in Andhra Pradesh, as
new services are being initiated at relatively smaller health
facilities where the number of HIV positive mother-
neonate pairs may not be high. Importantly, since April
2006, the government has started over 350 integrated
counselling and testing centres (ICTCs) at relatively
smaller community health centres and primary health
centres in Andhra Pradesh to provide both VCT and
PMTCT services at one place. In the background of poor
efficiency of isolated PMTCT services found in our study
at smaller facilities with relatively low HIV prevalence, the
new approach of combining VCT and PMTCT services
seems justified. This approach is likely to enhance effi-
ciency at smaller facilities but would have to be studied
for proper understanding of how this can yield optimal
advantages. This integration of services approach is now
recommended by India's National AIDS Control Organi-
zation and is also being applied to larger health facilities
where VCT and PMTCT services existed earlier, combining
them under the umbrella of ICTCs [14]. Where applica-
ble, linkage of ICTCs with other related services such as
those for tuberculosis and sexually transmitted infection
as well as HIV/AIDS treatment and care, are also being
attempted. These efforts are in an early stage and would
have to be monitored as they evolve.
The relation between unit cost and scale reported in this
paper for PMTCT and that reported earlier for VCT by us
[7], and our recent analysis of the changing cost of VCT in
Andhra Pradesh over a period of three years [12], can use-
fully inform further planning of PMTCT and VCT services
in this India state. It would also be useful to subsequently
compare the outputs and efficiency of the new ICTC
approach with our current findings to assess the advan-
tages that may accrue with the new integrated approach.
PMTCT is receiving increasing attention globally as an
important component of HIV control [15]. Cost-effective-
ness data have been reported for PMTCT from other parts
of the world, mainly sub-Saharan Africa [16-19]. The effi-
Relation between scale and cost per mother-neonate pair  who received nevirapine for PMTCT centres at hospitals  attached to medical college (upper) and those not attached  to a medical college (lower) in the 2005–2006 fiscal year Figure 2
Relation between scale and cost per mother-neonate pair 
who received nevirapine for PMTCT centres at hospitals 
attached to medical college (upper) and those not attached 
to a medical college (lower) in the 2005–2006 fiscal year.
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Relation between scale and cost per post-HIV-test coun- selled pregnant woman for PMTCT centres at hospitals  attached to a medical college (upper) and those not attached  to a medical college (lower) in the 2005–2006 fiscal year Figure 1
Relation between scale and cost per post-HIV-test coun-
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ciency data reported by us could form the basis of cost-
effectiveness calculations in India if supplemented with
additional data and analyses, which could further inform
decisions about how best to use the available resources for
HIV control in India.
Conclusion
The inverse relation between unit cost and scale for pre-
vention of mother to child transmission of HIV services,
and the extremely high unit cost at some centres providing
nevirapine to a very small number of mother-neonate
pairs annually, needs to be taken into account for further
planning of services in this Indian state for prevention of
mother to child transmission of HIV. Combining PMTCT
and VCT services would be the preferred approach to
increase efficiency, particularly at relatively smaller cen-
tres.
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